Stock Research for VRML


Featured Broker: Ally Invest

Get the due diligence for another stock.


VRML Stock Chart & Research Data

The VRML chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VRML chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


VRML Due diligence Resources & Stock Charts

The VRML stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VRML Detailed Price Forecast - CNN Money CNN View VRML Detailed Summary - Google Finance
Yahoo View VRML Detailed Summary - Yahoo! Finance Zacks View VRML Stock Research & Analysis -

Stock Analysis

TradeIdeas View VRML Trends & Analysis - Trade-Ideas Barrons View VRML Major Holders - Barrons
NASDAQ View VRML Call Transcripts - NASDAQ Seeking View VRML Breaking News & Analysis - Seeking Alpha
Spotlight View VRML Annual Report - OTC Report View VRML OTC Short Report -
TradeKing View VRML Fundamentals - TradeKing Charts View VRML SEC Filings - Bar Chart
WSJ View Historical Prices for VRML - The WSJ Morningstar View Performance/Total Return for VRML - Morningstar
MarketWatch View the Analyst Estimates for VRML - MarketWatch CNBC View the Earnings History for VRML - CNBC
StockMarketWatch View the VRML Earnings - StockMarketWatch MacroAxis View VRML Buy or Sell Recommendations - MacroAxis
Bullish View the VRML Bullish Patterns - American Bulls Short Pains View VRML Short Pain Metrics -

Social Media Mentions

StockTwits View VRML Stock Mentions - StockTwits PennyStocks View VRML Stock Mentions - PennyStockTweets
Twitter View VRML Stock Mentions - Twitter Invest Hub View VRML Investment Forum News - Investor Hub
Yahoo View VRML Stock Mentions - Yahoo! Message Board Seeking Alpha View VRML Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for VRML - Insider Cow View Insider Transactions for VRML - Insider Cow
CNBC View VRML Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VRML - OTC Markets
Yahoo View Insider Transactions for VRML - Yahoo! Finance NASDAQ View Institutional Holdings for VRML - NASDAQ

Stock Charts

FinViz View VRML Stock Insight & Charts - StockCharts View VRML Investment Charts -
BarChart View VRML Stock Overview & Charts - BarChart Trading View View VRML User Generated Charts - Trading View

Latest Financial News for VRML

Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell
Posted on Thursday September 06, 2018

“September is an opportunity for us to reach more women and raise awareness around ovarian cancer,” said Valerie Palmieri, President and CEO of Vermillion, Inc.   “We are working every day to change the status quo and lead the charge in better, and earlier, detection of ovarian cancer. Vermillion’s proprietary technologies, OVA1®, and Overa are FDA-cleared blood tests to evaluate cancer risk in a pelvic mass, helping healthcare providers and women assess risk prior to surgery.  It is well documented that women with high risk of cancer can improve their survival rate by up to 40% by getting to a gynecologic oncologist for the first surgery and today 2/3 of women do not use the right specialist.

Edited Transcript of VRML earnings conference call or presentation 9-Aug-18 8:30pm GMT
Posted on Tuesday August 28, 2018

Q2 2018 Vermillion Inc Earnings Call

Vermillion, Inc. Appoints Nancy Cocozza to its Board of Directors
Posted on Tuesday August 21, 2018

Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced the appointment of Nancy G. Cocozza to its Board of Directors.  Ms. Cocozza joins the Board effective August 17, 2018, and brings the Board composition to six members. “We warmly welcome Nancy to our Board,” said Valerie Palmieri, President and CEO of Vermillion.  “Nancy will be a tremendous asset to us, as she brings over three decades of managed care leadership and reimbursement experience.

Vermillion: 2Q Earnings Snapshot
Posted on Thursday August 09, 2018

The Austin, Texas-based company said it had a loss of 4 cents per share. The diagnostic and bio-analytical company posted revenue of $708,000 in the period. In the final minutes of trading on Thursday, ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.